Noesis Capital Mangement’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.18M Sell
8,900
-229
-3% -$53.3K 0.32% 42
2025
Q4
$1.89M Sell
9,129
-2
-0% -$395 0.27% 41
2025
Q3
$1.69M Sell
9,131
-170
-2% -$29.1K 0.26% 41
2025
Q2
$1.42M Buy
9,301
+270
+3% +$41.5K 0.25% 44
2025
Q1
$1.5M Buy
9,031
+971
+12% +$152K 0.3% 41
2024
Q4
$1.17M Sell
8,060
-432
-5% -$66.9K 0.22% 46
2024
Q3
$1.38M Buy
8,492
+410
+5% +$65.3K 0.27% 43
2024
Q2
$1.18M Buy
8,082
+51
+0.6% +$7.58K 0.26% 43
2024
Q1
$1.27M Buy
8,031
+1,410
+21% +$224K 0.28% 43
2023
Q4
$1.04M Sell
6,621
-943
-12% -$145K 0.24% 45
2023
Q3
$1.18M Buy
7,564
+340
+5% +$56.1K 0.31% 42
2023
Q2
$1.2M Buy
7,224
+46
+0.6% +$7.42K 0.29% 43
2023
Q1
$1.11M Sell
7,178
-434
-6% -$70.1K 0.28% 43
2022
Q4
$1.34M Sell
7,612
-3,802
-33% -$656K 0.38% 41
2022
Q3
$1.86M Buy
11,414
+632
+6% +$107K 0.57% 38
2022
Q2
$1.91M Buy
10,782
+2,483
+30% +$442K 0.57% 39
2022
Q1
$1.47M Sell
8,299
-1,482
-15% -$252K 0.35% 41
2021
Q4
$1.67M Sell
9,781
-182
-2% -$29.8K 0.34% 42
2021
Q3
$1.61M Buy
9,963
+1,717
+21% +$293K 0.31% 42
2021
Q2
$1.39M Sell
8,246
-200
-2% -$33.1K 0.28% 46
2021
Q1
$1.39M Sell
8,446
-97
-1% -$15.7K 0.31% 43
2020
Q4
$1.34M Sell
8,543
-570
-6% -$84.1K 0.33% 43
2020
Q3
$1.36M Buy
9,113
+21
+0.2% +$3.11K 0.38% 44
2020
Q2
$1.28M Sell
9,092
-718
-7% -$105K 0.4% 41
2020
Q1
$1.29M Sell
9,810
-175
-2% -$24.8K 0.47% 38
2019
Q4
$1.46M Sell
9,985
-354
-3% -$48K 0.41% 40
2019
Q3
$1.34M Buy
10,339
+409
+4% +$53.9K 0.43% 37
2019
Q2
$1.38M Sell
9,930
-684
-6% -$94.7K 0.47% 36
2019
Q1
$1.48M Sell
10,614
-254
-2% -$34K 0.54% 34
2018
Q4
$1.4M Buy
10,868
+274
+3% +$38.2K 0.57% 35
2018
Q3
$1.46M Sell
10,594
-84
-0.8% -$11.2K 0.51% 33
2018
Q2
$1.3M Buy
10,678
+22
+0.2% +$2.75K 0.48% 35
2018
Q1
$1.37M Sell
10,656
-1,771
-14% -$239K 0.51% 37
2017
Q4
$1.74M Sell
12,427
-679
-5% -$94.6K 0.62% 35
2017
Q3
$1.7M Sell
13,106
-13
-0.1% -$1.72K 0.64% 36
2017
Q2
$1.74M Sell
13,119
-23
-0.2% -$2.93K 0.67% 36
2017
Q1
$1.64M Buy
13,142
+257
+2% +$30.7K 0.62% 39
2016
Q4
$1.49M Hold
12,885
0.62% 37
2016
Q3
$1.52M Buy
12,885
+71
+0.6% +$8.61K 0.66% 37
2016
Q2
$1.55M Buy
12,814
+6,073
+90% +$690K 0.69% 35
2016
Q1
$729K Buy
6,741
+160
+2% +$16.6K 0.33% 48
2015
Q4
$676K Buy
6,581
+138
+2% +$13.9K 0.32% 49
2015
Q3
$601K Buy
6,443
+300
+5% +$29K 0.32% 48
2015
Q2
$599K Sell
6,143
-75
-1% -$7.51K 0.26% 76
2015
Q1
$625K Sell
6,218
-215
-3% -$21.9K 0.26% 76
2014
Q4
$673K Buy
6,433
+172
+3% +$18.1K 0.28% 70
2014
Q3
$667K Sell
6,261
-43
-0.7% -$4.46K 0.29% 71
2014
Q2
$660K Sell
6,304
-832
-12% -$84.1K 0.3% 73
2014
Q1
$701K Buy
7,136
+588
+9% +$54.5K 0.34% 70
2013
Q4
$600K Buy
6,548
+98
+2% +$9.03K 0.3% 72
2013
Q3
$559K Hold
6,450
0.29% 80
2013
Q2
$554K Buy
+6,450
New +$547K 0.3% 81

Other funds holding JNJ

Noesis Capital Mangement's JNJ Position: Q1 2026 in Review

Noesis Capital Mangement reduced its Johnson & Johnson (JNJ) stake by 2.5% in Q1 2026, selling an estimated $53.3K and leaving 8,900 shares worth $2.18M. The position accounts for 0.32% of the portfolio, ranked #42.

Noesis Capital Mangement first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Noesis Capital Mangement held 8,900 shares of Johnson & Johnson worth $2.18M as of Q1 2026.
  • Noesis Capital Mangement sold 229 Johnson & Johnson shares in Q1 2026, an estimated $53.3K.
  • Johnson & Johnson made up 0.32% of Noesis Capital Mangement's portfolio in Q1 2026, its #42 holding.
  • Noesis Capital Mangement first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Noesis Capital Mangement's 13F filing for Q1 2026, filed 5 May 2026.